Lineage begins study of OPC1 delivering device for spinal cord injury treatment
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.3cY8rBmp.js ...
Too Old to Operate2 天
EVT for Large Ischemic Strokes With e-ICA Occlusion
The following is a summary of “Endovascular Thrombectomy for Extracranial Internal Carotid Artery Occlusions With Large ...
Pancreatic blood vessel cell map reveals potential diabetes treatment pathways
The distinct population of endothelial cells that line blood vessels in the insulin-producing "islets" of the human pancreas ...
Lineage Cell Therapeutics initiates study of OPC1 for spinal injury
Lineage Cell Therapeutics (LCTX) announced that the Company has initiated the DOSED clinical study. The DOSED study will evaluate the safety ...
Lineage Initiates Clinical Study of OPC1 for Spinal Cord Injury
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for serious neurological conditions, announced today that ...
Too Old to Operate3 天
Pulmonary Function Subgroups and Respiratory Risks in Preterm Infants
The following is a summary of “Physiologic Pulmonary Phenotyping of Infants Born Preterm and Post-Discharge Respiratory ...
Medscape4 天
Brain Metastasis Patterns Affect Breast Cancer Survival
Patients with ERBB2-positive breast cancer and CNS-only metastasis are at a high risk for CNS-related death but have longer overall survival than those with concomitant extracranial metastases.